Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
HRS 25: The BIO-LIBRA Study
Author(s): Valentina Kutyifa Added: 1 month ago
HRS 2025 - Contemporary outcomes from implantable devices in non-ischemic cardiomyopathy patients observed more advanced heart failure symptoms in women at the time of ICD implantation, and white women implanted with CRT-D devices had significantly lower ventricular arrhythmia events compared to men of all races and black women implanted with both device types.Dr Valentina Kutyifa (University of… View more

Demographic

Electrophysiology & Arrhythmia
AFSymposium 24: LAA Exclusion in Addition to PVI for Non-paroxysmal AFIB
Author(s): Dhanunjaya Lakkireddy Added: 1 year ago
AFSymposium 2024 — In this interview, investigator, Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute, US) shares the key findings from the aMAZE Continued Access Protocol (AtriCure).This study is the extension of the aMAZE Trial investigation in the form of a nested, non-randomised registry. The study looked at the LARIAT System, which percutaneously isolates and ligates the left… View more

Electrophysiology & Arrhythmia
LB-NICM: New Approach
Author(s): Shunmuga Sundaram Ponnusamy , Pugazhendhi Vijayaraman , Kenneth Ellenbogen Added: 9 months ago

Heart Failure

Electrophysiology & Arrhythmia
tVNS in POTS
Author(s): Praloy Chakraborty , Kassem Farhat , Lynsie Morris , et al Added: 1 year ago

Electrophysiology & Arrhythmia
ESC 23: MULTISTARS AMI Trial
Author(s): Linda Joosten Added: 1 year ago
ESC 2023 — Dr Linda Joosten (Julius Center for Health Sciences and Primary Care, NL) joins us to discuss the findings of the FRAIL-AF trial. FRAIL-AF is a multicentre, open-label randomised controlled clinical trial which studied frail elderly patients who receive vitamin K antagonist (VKA) treatment for atrial fibrillation (AF). Current clinical guidelines recommend non-vitamin K antagonists … View more

Anticoagulation

Demographic
EHRA 24: A Substudy of NOAH-AFNET 6
Author(s): Julius Nikorowitsch Added: 1 year ago
EHRA 24 - We are joined onsite by Dr Julius Nikorowitsch (University Heart and Vascular Centre Hamburg (UHZ), DE) to outline the impact of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation in a substudy of the NOAH-AFNET 6 trial (NCT02618577).The substudy consisted of 2534 patients from… View more

Electrophysiology & Arrhythmia
Functional Substrate Mapping
Author(s): Jaffar Al-Sheikhli , Patrick Tran , Rafaella Siang , et al Added: 6 months ago

Electrophysiology & Arrhythmia
Ventricular Tachycardia Ablation: Meta-analysis of Randomised Trials
Author(s): Rohin K Reddy , James P Howard , Yousif Ahmad , et al Added: 1 year ago

Electrophysiology & Arrhythmia
European Heart Rhythm Association (EHRA) Congress 2024 Reveals its Late-Breaking Clinical Trial Presentations for 2024
Added: 1 year ago Source:  EHRA 2024
The European Heart Rhythm Association (EHRA) Congress has announced four late-breaking clinical trial sessions to be presented in April.EHRA 24 will take place in Berlin and online from the 7th to the 9th April 2024. Access the full programme here.For short, concise coverage of the key data revealed, check out our video collection with Expert Interviews and Highlights, focussing on the results,… View more
Heart Rhythm 2025
Added: 3 months ago Source:  Heart Rhythm 2025
Heart Rhythm 2025 has released its program featuring five late-breaking clinical trials and science sessions which will take place from the 25th to 27thApril. The meeting is located in San Diego Convention Center, California. Access the full programme here.Late-Breaking Clinical Trials and Science: Clinical Trials Updates and RegistriesFriday 25th April, 11:45 – 12:45pm (PDT)A Multielectrode… View more

Electrophysiology & Arrhythmia